Conference Exhibitors

Abbott is a global leader in point-of-care (POC) diagnostics with a comprehensive portfolio of rapid tests, services, and handheld devices for use in a wide variety of healthcare settings: labs, clinics, remote healthcare outposts, retail outlets, the patient’s bedside and at home. Abbott’s offering of near-patient tests and services spans key health and therapeutic areas, including infectious disease, cardiometabolic, informatics, toxicology and consumer diagnostics.

ALTURiX have a growing range of products across multiple therapy areas. We are a dynamic pharmaceutical company, who are committed to building and nurturing meaningful partnerships with our customers in the UK. We are dedicated to delivering a growing portfolio of high quality products helping improve patient outcomes, at responsible prices. This is in accordance with our values of Integrity, Partnership and Reliability. We look forward to meeting you at PCRS, stand 31!

Established in 2009, Aspire Pharma has become one of the fastest growing pharmaceutical companies in the UK. Supplying a range of pharmaceuticals and medical devices, Aspire’s products are carefully selected to deliver value and differentiation to both patients and prescribers. Thanks to the company’s continued expansion, it is now a significant employer in the East Hampshire area, and continues to focus on extending its portfolio of innovative products, as well as furthering its position in the areas of ophthalmology and urology. For more information on the company and their products, visit www.aspirepharma.co.uk.

AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its medicines are used by millions of patients worldwide.

With a proud 100-year heritage in advancing UK science, today AstraZeneca is the UK’s leading biopharmaceutical company. AstraZeneca is based in six different locations across the UK, with its global headquarters in Cambridge. In the UK, around 8,600 employees work in research and development, manufacturing, supply, sales, and marketing. We supply around 35 different medicines to the NHS.

For more information, please visit www.astrazeneca.co.uk and follow us on Twitter @AstraZenecaUK.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas- Oncology, Cardiovascular, Renal & Metabolism and Respiratory. For more information, please visit www.astrazeneca.co.uk.

Asthma Patients Can Now Breathe Easy.
CAIRE® Diagnostics enables asthma patients to live with confidence through better monitoring and control. CAIRE® Diagnostics manufactures Fenom Pro®, a simple, easy to use, point of care device that measures Fractional exhaled Nitric Oxide (FeNO). FeNO is an accepted biomarker for inflammation associated with allergic asthma. CAIRE® Diagnostics is working to create broader access to FeNO testing for all asthmatics regardless of where they seek care around the world. Find out more about CAIRE® Diagnostics and Fenom Pro® at www.fenomasthma.com.

Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused biopharmaceuticals group with over 85 years’ experience in the pharmaceutical sector operating in 30 countries, employing around 6,000 people. The Group’s research and development centre in Parma works alongside six other important R&D hubs in France, the US, Canada, China, the UK, and Sweden. Chiesi develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. As a certified B Corp since 2019, Chiesi is part of a global community of businesses that meet high standards of social and environmental impact. The company aims at becoming net-zero by 2035. Chiesi Limited is headquartered in Manchester and employs over 400 people. Further information: www.chiesi.uk.com

About Us

At Cipla, we constantly work towards ensuring access to high quality and affordable medicines to support patients in need, which is why, we have been trusted by healthcare professionals and patients across geographies for the last 8 decades.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

For over eight decades, making a difference to patients has inspired every aspect of Cipla’s work. Our paradigm-changing offer of a triple anti-retroviral therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 is widely acknowledged as having contributed to bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. A responsible corporate citizen, Cipla’s humanitarian approach to healthcare in pursuit of its purpose of Caring for Life and deep-rooted community links wherever it is present making it a partner for global healthcare stakeholders.

With devices such as its Mini-Wright Peak Flow Meter recognised in the industry as “The Gold Standard” for Expiratory Flow Measurement, CCI has also forged strong relationships with Health Care Professionals to deliver patient solutions that support correct inhaler use and technique.
CCI is now part of the Flexicare Group; Flexicare is a leading designer and global provider of innovative medical devices.
Headquartered in the UK, our global network of 17 subsidiaries supports over 105 countries with dedicated in-market clinical experts and customer service centres.

NIOX® develops and produces state-of-the-art technology for asthma diagnosis and management. Our aim is to improve the lives of millions of people suffering from asthma by helping physicians assess patients more accurately. Our market-leading device, NIOX VERO®, measures the level of fractional exhaled nitric oxide (FeNO) in the breath, with results proven to help with asthma treatment.

We’re celebrating 25 years of NIOX® technology in 2023! As the first to market with a portable analyser to maximise access to FeNO and nNO testing, we’re proud to say NIOX VERO® remains the gold standard device, with nearly 50 million tests performed worldwide and counting. NIOX.com

GSK has been a leader in respiratory for more than 50 years, helping patients with respiratory disease better manage their condition. Working in collaboration with the scientific community, GSK remains at the cutting edge of scientific research into innovative medicines with the aim of helping patients’ symptoms and reduce the risk of their disease. For further information for UK HCPs, please visit https://gskpro.com/en-gb/

NP-GB-RS-WCNT-220003, September 2022

Glenmark Pharmaceuticals Europe Limited
Founded 45 years ago, Glenmark Pharmaceuticals is a global pharmaceutical company with a track record of achievement, improving patients’ lives with access to affordable medicines. As a global leader in generics, we are leveraging our industry expertise and success to fuel extensive research and develop innovative, branded products that will have a major impact on how people live. We are also active in supplying medicines to NHS Hospitals.

GSK has been a leader in respiratory for more than 50 years, helping patients with respiratory disease better manage their condition. Working in collaboration with the scientific community, GSK remains at the cutting edge of scientific research into innovative medicines with the aim of helping patients’ symptoms and reduce the risk of their disease. For further information for UK HCPs, please visit https://gskpro.com/en-gb/.

Intermedical is an established and a highly reputable distributor of innovative respiratory technologies and solutions. The Cardio Respiratory division of Intermedical is focused primarily on delivering our specialist range of monitoring and diagnostic equipment including FeNO and Spirometry.

At Kenvue, we realize the extraordinary power of everyday care. Through our iconic brands, we put this power into the hands of 1.2 billion people globally – in their daily rituals and the moments that matter most. We are 22,000 dynamic and diverse team members, passionate about insights, innovation and making an impact. We are united by an unwavering courage to see and solve everyday care needs by delivering science-backed, care-forward experiences that are endorsed by healthcare professionals. With expertise and empathy, we believe in endless possibilities for healthier people and a healthier planet. And we’re relentless in their pursuit. As the world’s largest pure-play consumer health company by revenue, we bring a new view of everyday care to the world.

National Services for Health Improvement (NSHI) Ltd. www.nshi.co.uk are an independent service provider committed to delivering both in-practice and remote health care services that make a real difference to patients. As a leading supplier of specialist nursing services to both the NHS and Pharmaceutical sector our teams have helped to support patients in over 6,500 practices and 25 Hospital Trusts. We have provided review services for patients with asthma, COPD, cardiovascular disease, migraine other long-term conditions. In addition, we also provide locality wide services for spirometry assessment and the national immunisation programme.

NSHI look to embrace healthcare technology and have global leading medical software solutions that we have developed alongside our sister organisation LungHealth www.lunghealth.co.uk

We provide patient identification, risk stratification and patient review solutions (guided consultation software). Our COPD and Sleep software solutions are now NHS Framework (LPP) listed and have ORCHA digital accreditation. The products are designed to support practices who may not have the benefit of specialist respiratory nurse resource or to augment existing specialist resource in Hospital Trusts.

Highly skilled specialist nurses, together with cutting edge technology will see our healthcare solutions rolled out into other countries outside of the UK in the forthcoming years as we look to grow our global presence.

NSHI are committed to reducing health inequality and reducing variability of patient outcomes which remain a challenge in today’s NHS.

SPIROCONNECT SPIROMETER
SpiroConnect is the most accurate, comprehensive, and simple to use spirometry solution available. Bluetooth connectivity allows the respiratory nurse to be isolated from the patient during a test if necessary, giving extra protection should a coughing event occur. SpiroConnect is fully integrated with EMIS, SystmOne and Vision making it safer, faster and easier to use. It is also fully compliant with the latest ATS/ERS 2019 spirometry update. In addition to all of the features that you would expect in a leading spirometry system, ArtiQ.Spiro quality and interpretation reports are also available for those users with an active ArtiQ.Spiro account.

SpiroConnect can be purchased outright or rented from just £41 + VAT per month, including installation, product training, clinical system integration and Numed's comprehensive MediServe support package.

WHAT DO OUR CUSTOMERS THINK?
“As a Respiratory Nurse Specialist with over 14 years’ experience delivering spirometry training in the Primary Care sector, I have used all makes and models of spirometer. I was introduced to the SpiroConnect system around 6 years ago. The design, accuracy and ease of use of SpiroConnect, in addition to after sales support and commitment to product development is the best I’ve ever experienced. I now recommend SpiroConnect to any practice/hub looking to upgrade their spirometry equipment” - SOPHIE TOOR – Primary Care Respiratory Nurse Specialist and Clinical Director of Respiratory Matters, a leading spirometry training provider.

FeNO AND CO BREATH TESTING
New to our respiratory range are the Bedfont NObreath FeNO monitor and a range of Carbon Monoxide breath testing equipment from MD Diagnostics.

For more information, visit the Numed Healthcare stand at the PCRS exhibition or contact us:

Website: www.numed.co.uk
Email: info@numed.co.uk
Telephone: 0114 2433896

NuvoAir is a digital health company that partners with the NHS to help patients with heart and lung conditions understand and better manage their health, through high quality specialist remote monitoring.

Our devices remotely collect biomarkers to empower the best clinical decisions, while being easy to use for patients from the comfort of their homes.

Care coordination

NuvoAir Care Coordinators work with care teams to provide a consistent point of contact for patients with complex needs, relieving workforce pressure by utilising ARRS funding for additional roles.

Diagnostic pathways

Our remote assessments, facilitated by respiratory physiologists, increase the capacity of clinical teams to accurately diagnose conditions such as asthma, COPD, and congestive heart failure (CHF).

NuvoAir is your value-based care provider that empowers and engages people with complex cardiopulmonary conditions. We deliver continuous, proactive, and personalised care at-scale through a virtual care model that integrates the best of multidisciplinary care, connected devices, and behavioural change models to improve outcomes and reduce costs.

With offices in Boston, MA and Stockholm, Sweden, NuvoAir is a leading digital health company for chronic disease management and decentralised clinical trials.

https://www.nuvoair.com/

Orion Pharma (UK) Ltd is a wholly owned subsidiary of Orion Corporation, pharmaceutical
company based in Finland. Our principal role is to represent Orion's pharmaceutical products in
the UK with a focus on Prescription Only Medicine (POM).
In the spirit of the values which are common to all units and employees of the Group, we
endeavour to provide innovative medicinal treatments and best quality service to patients,
healthcare professionals and the community in the UK, the region we operationally cover.
Orion carries out extensive research with a goal of introducing new treatments into global
markets. The core therapy areas of Orion are neurological disorders, oncology and respiratory
disease.
www.orionpharma.co.uk
August 2022/CORP-233(1)

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. In the UK, Pfizer has its business headquarters in Surrey and is a major supplier of medicines to the NHS. To learn more about our commitments, please visit us at www.pfizer.co.uk or follow us on Twitter (@Pfizer_UK), Facebook (@PfizerUK) and Instagram (@pfizeruk).

PP-UNP-GBR-0951 June 2022

Pulmonx is a global leader in interventional pulmonology, planning tools, and treatments for obstructive lung disease and is the maker of the Zephyr Endobronchial Valve. Zephyr Endobronchial Valves are a NICE approved and NHS England commissioned, minimally invasive treatment for lung volume reduction in breathless patients with Severe Emphysema.

We are an educational establishment with over 20 years of experience providing evidence-based education for Health Care Professionals. We believe that our expertly developed courses offer a way of learning that translate to clinical practice giving healthcare professionals the knowledge and confidence to provide excellent, person-centred care to people with long term conditions.

We chase the miracles of science to improve people's lives.
We transform scientific innovation into healthcare solutions for people nationwide and across the globe.

Smart Respiratory enables clinicians to digitally monitor patients’ asthma status between consultations via the Smart Asthma Home Diagnosis and Monitoring Kit and Dashboard. ICSs and Trusts conduct QIPs with outcomes to diagnose or re-assess asthma referrals, reduce outpatient appointments, and reduce reliever inhaler use. Visit our stand for a demo.

Thornton & Ross, part of the STADA group, focuses on caring for people’s health through a broad portfolio including generics, biosimilars and non-prescription consumer healthcare products as a trusted partner supplying the NHS. STADA sells its products in more than 120 countries, employing over 12,000 people worldwide.

Based in the UK, Stirling Anglian is committed to medicines optimisation. It has sourced and developed a portfolio of medicines to help the NHS curb waste – across a range of conditions that currently place unnecessary and avoidable pressure on NHS resources. At a time when there is such pressure on the NHS to reduce costs we believe we offer a real and practical solution.

We work closely with stakeholders across the NHS to identify real-world problems, and develop value-based solutions that support the delivery of efficient and cost-effective healthcare.

As a global leader in Allergy and Autoimmune diagnostics, we are committed to providing accurate disease diagnosis. We offer over 650 allergen tests and a range of autoimmune test including EliA Coeliac testing, referenced in over 6,000 publications and guidelines. ImmunoCap is considered the Gold Standard in Specific IgE blood testing.

Our mission is to transform respiratory care pathways with AI-driven diagnostic and monitoring technologies. We produce the N-Tidal, a powerful tool for diagnosing, monitoring and improving respiratory health through a best in class sensor, an easy-to-use device and platform driven by exponentially powerful AI.

Trion Pharma is a rapidly growing UK based Nutraceutical, Pharmaceutical and Medical Device company that researches and develops innovative, quality, cost-effective products that will improve the health and well-being of people. We are an ethical pharmaceutical company that helps the NHS to save more on drug budgets, without compromising on quality.

We do have the most cost and clinically effective respiratory product range including Medical Devices which makes right product selection with significant NHS cost savings for healthcare professionals.

Some of the products including medical devices are as follows.

1) EasyChamber Anti-Static Spacer Device, available with 4 variants.

EasyChamber Mouthpiece
EasyChamber with Adult Mask
EasyChamber with Child Mask
EasyChamber with Infant Mask.

2) Easy Peak Flow Meter, available with 2 variants

Easy Peak Flow Meter Standard Range
Easy Peak Flow Meter Low Range

3) PulmoClear

To meet all clinical need available in Isotonic and Hypertonic Sodium Chloride Inhalation solution (Preservative Free)

PulmoClear 0.9% Isotonic Saline Inhalation Solution (Sodium chloride 0.9%)
PulmoClear 3% Hypertonic Inhalation Solution (Sodium chloride 3%)
PulmoClear 6% Hypertonic Inhalation Solution (Sodium Chloride 6%)
PulmoClear 7% Hypertonic Inhaltion Solution (Sodium Chloride 7%)


All the products are listed in Drug tariff.

All the products are readily available to pharmacies and dispensing practices from mainline wholesaler viz. Phoenix, AAH Pharmaceutical & Alliance Healthcare on same day or next day delivery. We also offer price and supply guarantees for these products.

Trudell Medical International works with patients, their caregivers and healthcare professionals to help patients all over the world breathe better and live fuller lives. We manufacture and globally market some of the leading brands in respiratory care including the AeroChamber* brand of spacers, Aerobika* OPEP devices, and AEROECLIPSE* BAN* nebulisers.

Vitalograph is celebrating 60 years as a global leader in respiratory diagnostics. We produce high quality, accurate, and reliable, respiratory medical devices & services for Primary Care, Secondary Care, Occupational Health, and Clinical Trials.

Our respiratory diagnostic range includes peak flow meters, lung monitors and screeners, PC-based, Handheld and Desktop Spirometers, ECG, FeNO, and full pulmonary function testing systems, as well as networking software and consumables.

The new range of spirometers are not just compliant with the 2019 ATS/ERS spirometry update, ensuring your service meets the latest international guidelines on accuracy and reporting but are design to automatically apply the new grading and provide quality control feedback for easy and rapid testing.

For further peace of mind our spirometers come with FREE 5 YEAR WARRANTY and FREE ONLINE DEVICE TRAINING and FREE CONNECT electronic medical record interface software.

Protect your patients, staff, and equipment with an Eco BVF™ manufactured in Ireland, suitable for most leading brands of spirometers. Independently validated 99.999% bacterial and viral cross-contamination efficiency, these filters are made using less plastic, are lighter to transport, and are made from 100% recyclable materials.
Visit our stand to see for yourself and discuss where we can help.
Visit www.vitalograph.co.uk or call 01280 827110.

Wockhardt UK is a leading supplier of medicines to the NHS.
Based in Wrexham, we have been partnering with the NHS to provide quality medicines in Primary and Secondary care for 60+ years.
We supply over 160 product lines including many critical medicines which are manufactured both from our sterile manufacturing suite in the UK, and across the world. We have an experienced supply team and robust supply chain for all our medicines. All support functions and teams are in one place enabling flexibility and rapid responses.
With decades of experience behind us, we are known for taking care of our customers with dedication and professionalism. With an expanding portfolio of branded generic products covering multiple therapy areas, we are helping to maximise Primary Care budgets across the UK.
By choosing Wockhardt as your reputable supplier of respiratory inhalers, you could benefit from excellent cost savings, responsive support and national distribution coverage.
Make sure you visit our stand to find out how Wockhardt UK’s branded generic medicines could benefit your patients and your prescribing budget and to get more information on our latest product launch!

At Zentiva, it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. Visit us at www.zentiva.co.uk